She couldn’t be more deserving. Her work in addressing anti-coagulant-related bleeding, preventing strokes in cancer patients, and reducing blood loss in critically ill patients is helping to reshape modern clinical practices. Dr. Siegal has secured over $22M in grant funding, has earned an h-index of 43, and has published over 150 peer-reviewed articles, including papers in some of the globe’s most influential, high-impact journals.
“I am fortunate to be a part of Ottawa's world-class medical research hub which has helped me expand the scope and impact of my research as a clinician-scientist ....”
Dr. Deborah Siegal
Dr. Siegal is an associate professor in the School of Epidemiology and Public Health as well as in the Department of Medicine. She’s also a hematologist (thrombosis medicine) and clinician-scientist at The Ottawa Hospital’s research institute.
In 2021, she was named as a Tier 2 Canada Research Chair in Anticoagulant Treatment of Cardiovascular Disease. In 2023, she was recognized as the early-career researcher of the year (clinical) at the Faculty of Medicine.
In a letter nominating Dr. Siegal for the CSCI’s Joe Doupe Young Investigator Award, Dr. Greg Knoll, chair of the Department of Medicine, described her as an extremely talented clinician-scientist and already an internationally recognized expert in cardiovascular and thrombotic disease.
“Her work on anticoagulation management, bleeding prevention, and perioperative care has had significant implications across clinical specialties, including transplantation, cardiovascular surgery, oncology, and critical care. Her research programs have contributed to improved perioperative care and reduced need for blood transfusions enabling safer and more effective treatment pathways for patients managing antithrombosis treatments,” Dr. Knoll wrote.
He added that her contributions to patient engagement, leadership, and the mentoring of emerging researchers and clinician investigators was just as impressive.
Dr. Siegal said the recognition from the Canadian Society for Clinical Investigation is a testament to the “incredible support” she’s received from her “community of colleagues, collaborators, mentors and trainees.”
She also credited the impact of being based in Ottawa’s robust medical research community.
“I am fortunate to be a part of Ottawa's world-class medical research hub which has helped me expand the scope and impact of my research as a clinician-scientist to improve the lives and health of people living with cardiovascular diseases,” she says.
The Joe Doupe Young Investigator Award includes a $1,000 cheque presented to the recipient at the time of an award lecture at the annual CSCI conference.